Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks MuchosWonga, greatly appreciated.
29th February
Does anybody know when Accustem Sciences shares should be allocated? I can't find any information at all.
Welcome back love singh
Ha.. have you listened to any of the conferences or the rns...... They have already said when topline data is due... Also a new Chief Medical officer from Regeneron doesn't join a failing company..... And patients started to get their smell back.... Tells you something
Ferocious excitement on the SNG board after RNS - over 100 posts before 7.45am - looks like breaking 2.00 today??
I expect if the results from Brazil trials are good then I expect us included in "Operation Warp Speed"!!!
I know like most of you that the results for the Brazil trial are very good! Hence why i have been paying £1.65p to buy more!
I hold some SNG and they have been included in "Operation Warp Speed"! But my 2nd biggest holding is TILS after VAL!
Good luck!
Reminder
Are the Brazil trials as successful as we are all hoping for?
The chairman isn’t going to say the results are poor and see a mass sell off.
The potentials hope for good news isn’t reflected in the share price. Perhaps others know something we don’t.
Reminder
They need to release it before the markets open tomorrow. Otherwise, it should wait with all the other big biotech news to be released next week.
https://finance.yahoo.com/news/week-ahead-biotech-jan-24-141404905.html
Results can be due any day....
Has the results date been moved to next week? Was that what the doctor said in the fireside chat?
https://markets.ft.com/data/equities/tearsheet/summary?s=TILS:LSE
The free float of shares is getting incredibly low now. Tils is ready to pop , bang, whizz !!!
"We don’t know that"
I do, as I said as this is not moving to a different phase there is no obligation to get FDA approval for dose expansion
I hope people absorb this.
We don’t know that, as and when results are released and a plan forward ,we are all in the dark,anything goes in this dark time WAKE UP.
The data would usually be peer reviewed but as this is not moving to a different phase there is no obligation to get FDA approval for dose expansion
Phase 3 is time and capital
On the odds you quote you could buy 2 different companies and have a 75% chance one of them pays off. Buy four and well....
You might be on to something.
With TILS the risk is not the molecule - route of administration. If they get their preclinical right it derisks phase 3 - you wouldn't do it if preclinical was poor.
Not long now , results , there a coming, ‘it works’ all ready in public domain, what’s not to like, confirmation in maybe a couple of weeks.
Why stall good results, well with so many nda’s I would assume they are going through it with a ‘fine tooth comb’ to be sure there offer will come good.
Assuming we get the hinted at positive RNS about the Brazil trials should we expect next steps in the same RNS?
Might be too much to expect a confirmed date for wider trials but there's no time to waste. It's this sort of thing I'd expect our new CMO to be on top of but he's only just started to be fair.
I see what you did.
Don’t forget Alzheimer’s!
I fully agree that TILS was never about Covid, but fortunately or unfortunately depending on your point of view, the nearest short term catalyst is indeed all about Covid. Hopefully the data will be positive with the Primary Endpoint being met, trial expansion, then focus can pivot to the other assets again.
I didnt get into this for the covid but for their pipeline .but if covid helps them fasttrack a good multi use drug then fantastic :)